🔓 Unlock the full profile of Alex Kotlar (Pillar Biosciences Incorporated), including verified contact details, financial insights, and professional associations.
See Alex Kotlar Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: ale*****@pil******.com
Mobile: 91584*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Alex Kotlar is the Co-Founder and CEO of Super Mysterious GenAI Life Sciences Company, which began operations in March 2024, indicating significant entrepreneurial initiative in the life sciences sector.
- Previously served as Associate Director and Head of Software/AI at Pillar Biosciences Incorporated from March 2023 to March 2024, showcasing expertise in software development and artificial intelligence applications in biosciences.
- Held multiple roles at Pillar Biosciences from 2021 to 2023, including Head of Bioinformatics and Senior Manager, contributing to advancements in bioinformatics and data science, essential for modern biotechnology.
- Experience as a Software Engineer II at Pillar Biosciences from 2020 to 2021, where innovative software solutions likely aided in research and clinical applications.
- Previous tenure at the Broad Institute of MIT and Harvard as a Software Engineer and Postdoctoral Research Fellow from December 2018 to October 2020, aligning with a strong foundation in computational biology.
- Engaged in postdoctoral research at both Mass General Hospital and Emory University, contributing to significant research projects from 2018 to 2020 and enhancing research capabilities in the biomedical field.
- Earned a PhD at Emory University in August 2018, underscoring a deep academic commitment and expertise in relevant scientific disciplines.
- Initial career roles included IT management and software development, establishing a technical foundation that supported transitions into more advanced positions in the life sciences and bioinformatics.
- Pillar Biosciences Incorporated, founded in 2014, has grown its workforce, indicating business sustainability and market relevance within the life sciences industry.
- Reported company growth metrics highlight the capacity for adaptation and development of solutions to meet evolving challenges in biosciences, fostering innovation and research advancements.